SensNews March 2020

Sensor100 Page 10 Quidel SARS-CoV-2 Test Receives Expanded FDA Emergency Use Authorization Quidel said after the close of the market onWednesday that it has received expanded Emergency Use Authorization from the US Food and Drug Administration for the Lyra SARS-CoV-2 assay. Under the expanded EUA, the assay can now be used with three ad- ditional thermocyclers, the Applied Biosystems 7500 Standard fromThermo Fisher Scien- tific, Roche’s LightCycler 480, and Qiagen’s Rotor-Gene Q. GenomeWeb 25 March Credo Diagnostics Biomedical announced it has obtained CE mark for an assay to detect SARS-CoV-2, the virus that causes coronavirus disease COVID-19.The test runs on the firm’s point-of-care instrument and is now commercially available on countries accepting the CE designation. GenomeWeb 18 March JN Medsys has developed two new coronavirus diagnostic kits to meet the surge in demand for COVID-19 diagnostics. Mayo Clinic,Amazon, others launch collaboration to increase COVID-19 test- ing Fierce Healthcare 25 March The Inflammacheck from Exhalation Technology is a CE marked Medical Diagnostic for profiling the breath of patients with chronic lung diseases.The Inflammacheck can profile the user’s breath for five biomarkers including their breath condensate hydrogen perox- ide concentration. Zimmer & Peacock are seeking partners to be part of repositioning the Inflammacheck for COVID-19 screening. FurtherTests in Development by Iceni Diagnostics and Mologic